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Learning Objectives
• Learn the current epidemiology of CF pathogens
• Consider routes of transmission of various CF pathogens
• Learn best practices to minimize the risks of acquisition and 
transmission of CF pathogens
Cystic Fibrosis Genetics
• Most common lethal genetic disease among Caucasians
• Autosomal recessive 
• Mutation in cystic fibrosis transmembrane conductance regulator 
(CFTR) gene
• cAMP regulated chloride channel located in apical membrane of 
glandular epithelium
• Located long arm of chromosome #7
• F508del most common mutation 
• 1700 identified mutations
Cystic Fibrosis Epidemiology
• 70,000 world wide
• 30,000 affected individuals in U.S. 
• 1 in 3,200 live births among Caucasians 
• 1 in  9,200 Hispanic
• 1 in 15,000 African Americans
• 1 in 25 carrier rate (unaffected) 
• 1,000 new cases per year 
o Newborn screening (NBS) in all states
o >60% of patients detected by NBS.
o 8% new diagnoses adults >18 years of age
Median Survival over time in U.S.
Respiratory disease main cause of morbidity 
and mortality 
U.S. CF Registry
Half of patients with CF in U.S. are adults
U.S. CF Registry
Age-Specific Prevalence of 
Respiratory Infections in CF Patients
Source: Cystic Fibrosis Foundation Patient Registry, Annual Data Report
Changing Prevalence of CF Pathogens
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• Improving lung function decreasing risk of infection
• Successful early eradication strategies for P. aeruginosa1
• Increase in community acquisition of MRSA2
• More rigorous infection prevention and control practices at CF centers3,4
1Treggiari et al. Arch Pediatr Adolesc Med. 2011;165(9):847–56.
2 Dantes R, et al JAMA Intern Med 2013;173(21):1970-8
3 Saiman L, et al. Infect Control Hosp Epid 2003;24(Suppl 5):S1-52
4 Saiman et al. Infect Control Hosp Epidemiol. 2014;35 Suppl 1:S1-S67.
Discussion 
• Changes to the CFFPR population during the study period
• Increased number of patients identified by newborn screening 
Major Routes of Transmission
of CF Pathogens               
Siegel JD, et al and HICPAC. 2007 Guideline for Isolation Precautions: Preventing 
Transmission of Infectious Agents in Healthcare Settings 
(www.cdc.gov/hicpac/pubs.html,  accessed 3.1.2013 or Am J Infect Control 2007; 35 
(suppl 2): S65-164 )
Indirect Contact Transmission
• Occurs when infectious agents are 
transferred through contaminated 
intermediate object or person
• Examples: Transfer of infectious 
agents via contaminated hands, 
contaminated respiratory therapy 
equipment, ommon items: eating 
utensils,  drinking glass, toys, etc. 
Siegel JD, et al and HICPAC. 2007 Guideline for Isolation Precautions: 
Preventing Transmission of Infectious Agents in Healthcare Settings 
Droplet Transmission
• Respiratory droplets carrying 
infectious agents travel from 
respiratory tract of infectious 
individual to susceptible 
mucosal surfaces of another 
person, generally over short 
distances (3-6 feet)
• Droplets generated by 
coughing, sneezing OR
procedures, e.g., pulmonary 
function tests or chest 
physiotherapy 
Festini F. Am J Infect Control 2010; 38: 244; Clifton IJ. Expert Rev Resp Med.2010; 
Wainwright CE. Thorax 2009; 64:926
Airborne Transmission
• Dissemination of droplet nuclei of 
respirable size containing infectious 
agents
• May remain suspended in air for 
prolonged periods of time and dispersed 
over long distances by air currents 
• Inhaled by susceptible individuals 
without face-to-face contact with 
infectious individual Strain variation of P. aeruginosa in ability             
to remain suspended in air. 
Clifton IJ. JCF 2010; 9:64
Evolving View of Droplet Transmission 
• Data from:
• Epidemiologic studies of outbreaks
• Experimental studies
• Aerosol dynamics
• Infectious droplets can remain suspended in 
the air 45 min. - 2 hrs.
• Experimental data from smallpox and SARS > 6 
ft.
• Experimental data in CF ~ 6 feet.
CDC. Isolation Guidelines 2007; Festini F. Am J Infect Control 2010; 38: 244; 
Clifton IJ. Expert Rev Resp Med.2010; Wainwright CE. Thorax 2009; 64:926; Zuckerman J 2012
Transmission of CF Pathogens and 
Associated Morbidity and Mortality
Pseudomonas aeruginosa
Liverpool Strain and Increased Risk of 
Mortality/ Transplant 








HR 3.26 (95% CI 1.41, 7.53, P=0.01)
Transmission of Multi-resistant 
P. aeruginosa (MRPA), Houston
• 2006: average MRPA in U.S. 16% vs. 30.1% 
in Houston
• 2004-2009 PA strains: 32 of 71 (45%) 
patients had strains with >95% similarity, 
aka Houston-1
• 12 more hospital-days year before 
Houston-1 acquisition
• Improved IP&C practices in clinic and 
hospital reduced acquisition
Luna RA, et al. J Clin Microbiol 2013; 51: 1237
























Distribution of Burkholderia spp., U.S.
• B. cenocepacia and B. multivorans most common 1997-2007
• B. multivorans now more frequent than B. cenocepacia
LiPuma JJ Clin Microbiol Rev 2010
B. dolosa: Morbidity and Mortality
Kalish LA, et al. Am J Resp Crit Care Med 2006;15:421-425.
• Case-control study
– 31 B. dolosa
– 24 B. multivorans
– 58 age-, sex-matched controls
• Increased decline lung 
function
• Increased 18-month 
mortality 
– 13% B dolosa






MRSA Impact: CFF Patient Registry, 
1996-2003
Dasenbrook EC et al. Am J Resp Crit Care Med 2008
• Mean 5.3 years follow-up
– 1,732 persistently (+)ve
– 13,922 never MRSA 
• 8-21 year olds 
– (+)ve MRSA FEV1 71.0% 
– Never MRSA FEV1 79.6% MRSA (+)ve: 43% 
more rapid decline
Dasenbrook, E. C. et al. JAMA 2010;303:2386-2392.
Impact of MRSA on Survival 
(N = 19,833)
Ad HR 1.27 (95% CI, 1.11, 1.45)
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Epidemiology of NTM in CF
• Described since 1970’s
• Variable prevalence 2-28%
Country Patients Species (%)
US 986 MAC (72%)
M. abscessus (16%)
France 385 M. abscessus (39%)
MAC (21%)
M. gordonae (18%)
Israel 186 M. Simiae (41%)
M. Abscessus (31%)
MAC (14%)
Olivier K Am J Resp Dis Crit Care Med 2003; Pierre-Audigier C et al. J Clin Microbiol
2005; Levy I et al. Emerg Infect Dis 2008
M. abscessus subspecies massiliense
• Index case: CF adult with multi-
drug resistant M. absessus ssp. 
massiliense for 7 years
• Transfer to clinic: AFB 4+ 
smear (+)ve
• Transmission: 4 additional CF 
adults (+)ve next 8 months
• 4/5 overlapping CF clinic days
• 3/5 died
Aitken ML, et al. Am J Respir Crit Care Med 2012;185(2):231-232.
M. abscessus ssp. massiliense
• Whole genome sequencing
NTM isolates, 2007-2011)
• 31 patients (+) M. abscessus
• 13 subsp. abscessus (6-patient cluster)
• 15 subsp. massiliense (2 clusters of 9 and 2 
patients)
• 9 patient massiliense cluster 
• More hospital exposure (10.8 vs. 1.2 d, p= 0.01)
• CF inpatient ward (5.7 vs. 1.5 d, p=0.01)
• CF clinic (3.9 vs. 2.3 d, p=0.02)
• Hospitalized same time as infected patient (4.2 
vs. 0.6 d, p=.005)
Bryant JM, et al. Lancet 2013; 381: 1551
Johnston DI, et al. J Hosp Infect 2016;94(2):198-200
Kapnadak SG, et al. Am J Infect Control 2016;44(2):154-59
Role of Healthcare Environment  
• P. aeruginosa in room air samples 
– obtained when waking up or after physiotherapy 
– 12/22 (55%) infected patients 
– 6/12 (50%) genetically identical to sputum strains
• Liverpool Epidemic Strain
– 5/8 (63%) air samples in CF clinic hallway
• Non-epidemic P. aeruginosa
– 3/15 (20%) PFT machine surface
• Pseudomonas and S. aureus
• 13.6% of sites in CF clinics contaminated
• hands (7%), exam room air (8%), environmental surfaces (1%)
• No differences in adults vs. children; routine vs. sick visit
Ferroni A., et al. J Cystic Fibrosis 2008; 7: 477. 
Panagea S. et al., J Hosp Infect 2005;59:102-107
Zuckerman H et al. J Cystic Fibrosis 2009; 8:186
Hands of People with CF, USA
• 74 patients hands cultured prior to performing  
alcohol hand hygiene at start of clinic visit 
• Hand hygiene reduced hand contamination
• But…patients’ hands contaminated at visit end 
Zuckerman JB, et al. J Cystic Fibrosis 2009; 8:186
KEY RECOMMENDATIONS
RECOMMENDATION KEY MESSAGES
Whenever feasible, provided choices for 
implementation strategies in healthcare settings.
Emphasized treating all people with CF the 
same…regardless of respiratory tract cultures. 
Assume all people with CF could have transmissible 
pathogens in respiratory tract secretions. 
No longer recommending different care practices for 
those infected with Burkholderia cepacia complex
Recommendations for non-healthcare settings and 
for healthcare professionals with CF intended to 
provide education to help make informed choices.
Use Principles of Adult Education
• Increase Knowledge of all providers 
• Perceive relevance of information to their personal situation
• Flexible
• Encourage networking, critical analysis, self-reflection on practice, 
opportunities for open questioning
• Increase awareness of guidelines
• Repeated exposures to information




• Acknowledge Impact of Attitudes
• Reflect individual beliefs, professional and personal life experiences
• Must believe practice change directly benefits themselves or patients 
Matlow AG. AJIC 2012; 40: 260 [environmental service workers]; Ferguson PE. BMT 2010;45:656 
[pt./families]; (Miroballi Y, Pediatric Pulm 2012;47:144 [CF patients and families]. 
Partner with Local IP&C Teams
• Both teams are data analysis/data driven
• Expertise of IP&C Teams
• Implementation, prioritization and staging of 
recommendations, if appropriate
• Identifying appropriate stakeholders, including  C suite
• Monitoring adherence to practices and providing feedback
• Apply experience with improving hand hygiene, respiratory 
hygiene, environmental cleaning, transmission precautions, and 
collaborations with microbiology lab 
• Audits of hand hygiene and cleaning practices
• Use existing tools for monitoring cleaning effectiveness 
• www.cdc.gov/HAI/toolkits/Evaluating-Environmental-Cleaning.html
Eckstein BC. BMC ID 2007; 7: 61; Hayden MK 2006; CID 2006; 42:1552;
Otter JA. ICHE 2011; 32: 687; Harris A. CID 2008; 46:686, Boyce JM. ICHE 2011; 32: 1187
Hand Hygiene (HH)
• Improve HH among Healthcare Providers:
– Prior to patient contact or after contact with body fluids or 
inanimate objects, e.g., equipment
– Make improvement institutional priority
– Make supplies readily accessible
• Improve HH among people with CF and families
CDC HH Guidelines 2002; WHO HH Guidelines 2003;
Use of Gowns, Gloves, Masks 
• Gowns and gloves 
• Staff wear when caring for all people with CF in hospital 
and ambulatory care areas
– Patients and families do not wear gowns and gloves
• Masks
– All people with CF wear surgical masks (if tolerated)
– Staff only wear surgical masks if suspected pathogen 
spread by droplets, e.g., influenza or pertussis
– Staff only wear N95 masks if suspected airborne pathogen, 
e.g., TB or measles
• 6 foot rule
Knibbs LD, et al. Thorax 2014;69(8):740-45.
Driessche KV, et al. Am J Respir Crit Care Med 2015;192:897-99.
Implementing Contact Precautions
• Pediatric CF center, USA (n=180)
• Measure pathogen revalence before and after all staff wore gowns 
and gloves for all CF patients
• Change in P. aeruginosa prevalence
• 30%  21% (p<0.001)
• Change in MRSA prevalence
• 10.8%  8.7% (p=0.008)
Savant AP et al. BMJ Qual Saf 2014;Suppl 1:i73-80
Transmission Precautions for 
Non-tuberculous Mycobacteria 
Insufficient evidence to place people with CF who are 
infected with NTM on Airborne Precautions, i.e., 
negative pressure room. 
Johnston DI et al. J Hosp Infect 2016;94(2):198-200.
Kapnadak SG et al. Am J Infect Control 2016;44(2):154-9.
Harris KA, et al. Clin Infect Dis 2015;60(7):1007-16.
Scheduling CF Clinics
Insufficient evidence to routinely scheduling CF 
clinics based on specific pathogens isolated 
from respiratory tract cultures.
4 Options for Performing PFTs 
1. In exam room at beginning of clinic visit
2. In a negative pressure room (Airborne Infection Isolation 
Room = AIIR)
3. In PFT lab with either portable or integrated high-
efficiency particulate [HEPA] filters  
4. In PFT lab without HEPA filtration, allowing 30 minutes to 
elapse before next person with CF enters PFT lab.
Zuckerman J et al. Am J Resp Crit Care Med 2015;191(5):598-601.
Psychosocial Impact IP&C Guidelines
• Centers should anticipate specific concerns regarding psychosocial 
impact of implementing IP&C recommendations
• Identify strategies to minimize negative impact
Somayaji R et al. BMC Pulm Med 2015;15:138.
Bowmer G et al. J Cystic Fibrosis 2017;16(1):146-50
Jain M, et al. Chest 2014;145:678-80
Shepherd SL et al. Chest 2014;145(4):680-83.
CF Foundation- and CF Center-sponsored 
Indoor Events
• Only one person with CF attend CFF- or CF Center-
sponsored indoor events (e.g., CF Education Days) 
unless they live in the same household. 
• Develop and utilize alternative CF education 
programs, (e.g., videotapes, video-conferencing, CD-
ROM web-based learning, Apps)
*CHESTJOURNAL
 UK CF Trust “…it is our policy for only one person with CF to be 
present…at an indoor event organised by Trust staff or its 
volunteer branches, groups, and committees… 
www.cysticfibrosis.org.uk/about-cf/living-with-cystic-
fibrosis/cross-infection.aspx
 CF Canada “For indoor events, a provision has made for 
organizers to invite one person with CF to attend.”
www.cysticfibrosis.ca/en/aboutUs/infectionControlPolicy
 Sponsored Pro-Con debate on this recommendation 
Jain M et al. and Shephard SL et al. Chest 2013, Oct 17
BALANCING INFECTION PREVENTION 






• The epidemiology of CF pathogens is changing; most notably the 
incidence and prevalence of P. aeruginosa are decreasing with the 
incidence and prevalence of MRSA are increasing
• Infection prevention and control may be reducing acquisition of some 
CF pathogens.
• New knowledge mandated new guidance for IP&C practices for CF.
• To be effective at preventing transmission of CF pathogens, IP&C has 
to be understood and practiced by everyone.
• Research directions suggested by recommendations with insufficient 
evidence.
Questions, Comments, Thoughts, 
Concerns????
